Table 3.
Statistic of molecular marker | Clinicopathologic factors (p-value only) | |||||
---|---|---|---|---|---|---|
Molecular marker | RR | CI | p-Value | Sex | Age (≥45 years) | Size (>2 cm) |
BRAFV600E | 1.69 | 1.11–2.57 | 0.01* | 0.52 | 0.85 | 0.01* |
miR-21 | 1.04 | 0.92–1.16 | 0.56 | 0.67 | 0.72 | 0.01* |
miR-146-3p | 1.10 | 1.02–1.19 | 0.01* | 0.96 | 0.98 | 0.01* |
miR-146-5p | 1.15 | 1.04–1.26 | 0.01* | 0.75 | 0.69 | 0.01* |
miR-204 | 0.96 | 0.88–1.04 | 0.30 | 0.54 | 0.80 | 0.01* |
miR-221 | 1.07 | 0.99–1.16 | 0.07 | 0.66 | 0.64 | 0.01* |
miR-222 | 1.16 | 1.03–1.30 | 0.01* | 0.47 | 0.76 | 0.01* |
miR-375 | 1.05 | 0.98–1.11 | 0.15 | 0.51 | 0.87 | <0.01* |
Each row represents an independent preoperative predictor model performed for CLNM. In the prophylactic cohort, independent preoperative predictors for CLNM were BRAFV600E mutation, miR-146b-3p, miR-146-5p, miR-222, and tumor size.
Statistically significant.